Vital Therapies reported $137.96M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Dynavax Technologies DVAX:US $ 422.8M 135.32M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
Epizyme EPZM:US $ 11.12M 31.81M
Insmed INSM:US $ 44.24M 75.64M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
Omeros OMER:US $ -4925000 28.7M
Orasure Technologies OSUR:US $ 364.89M 15.65M
Quidel QDEL:US $ 4919.6M 2504.68M
Regulus Therapeutics RGLS:US $ 49.24M 5.72M
Revance Therapeutics RVNC:US $ 25.54M 42.93M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Vital Therapies VTL:US $ 137.96M 10.85M
Xoma XOMA:US $ 134.96M 4.97M